Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Molecular Cancer Research : MCR|October 14, 2025
MDSCs in Breast Cancer: Metastasis, Lipid Metabolism, and TherapeuticsUkjin Kim, Rumela ChakrabartiSTAR Protocols|January 4, 2025
Protocol to detect neutral lipids with BODIPY staining in myeloid-derived suppressor cells in mouse mammary tumorsUkjin Kim, Rumela ChakrabartiBiochemical and Biophysical Research Communications|October 18, 2022
Hyperacetylation of the C-terminal domain of p53 inhibits the formation of the p53/p21 complexUkjin Kim, Kwang Seok Kim, Jong-Kuk Park, et al.Biochemical and Biophysical Research Communications|July 14, 2022
Involvement of the p53/p21 complex in p53-dependent gene expressionUkjin Kim, Kwang Seok Kim, Jong-Kuk Park, et al.Oncology Letters|August 4, 2021
Slug promotes p53 and p21 protein degradation by inducing Mdm2 expression in HCT116 colon cancer cellsJongdoo Kim, Jihyun Lee, Ukjin Kim, et al.Oncology Letters|September 26, 2018
Troglitazone inhibits the migration and invasion of PC-3 human prostate cancer cells by upregulating E-cadherin and glutathione peroxidase 3Seo-Na Chang, Ji Min Lee, Hanseul Oh, et al.Iscience|March 21, 2024
ΔNp63 regulates MDSC survival and metabolism in triple-negative breast cancerUkjin Kim, Rahul Debnath, Javier E Maiz, et al.Oncology Letters|March 29, 2021
Albendazole exerts antiproliferative effects on prostate cancer cells by inducing reactive oxygen species generationUkjin Kim, Changsoo Shin, C-Yoon Kim, et al.Pathology Oncology Research : POR|May 23, 2019
Correction to: Phloretin Inhibits the Human Prostate Cancer Cells through the Generation of Reactive Oxygen SpeciesUkjin Kim, C-Yoon Kim, Ji Min Lee, et al.Pathology Oncology Research : POR|April 3, 2019
Phloretin Inhibits the Human Prostate Cancer Cells Through the Generation of Reactive Oxygen SpeciesUkjin Kim, C-Yoon Kim, Ji Min Lee, et al.Pageof 3